Trodelvy and Leron were both trialed against soc (chemo).... who has the best numbers after side effects are included?..... we will have more survivability data in 10 days or less to present to FDA... and then we'll see who the new standard of care is!..... Keep in mind here are Trodelvy's side effects..... you literally have to hit the more button....they occured in 44% of patients....guess what, Leronlimab has none of these side effects.....

Nausea Diarrhea Feeling tired Decreased white blood cell count (neutropenia)
Hair loss Decreased red blood cell count (anemia) Vomiting Constipation Decreased appetite Rash Stomach-area (abdominal) pain or discomfort
TRODELVY can also cause serious side effects, including low white blood cell counts called neutrophils (neutropenia), severe diarrhea, serious infusion-related reactions and severe allergic reactions that can be life-threatening, and nausea.

Serious side effects occurred in 44% of patients receiving TRODELVY. The most common serious side effects in =5% of patients in the TRODELVY group were infection (18%), low white blood cell counts called neutrophils (12%), acute kidney injury (6%), urinary tract infections (6%), and blood infections (5%)